Understanding the distinction between these medications, their approved uses, and the regulatory landscape is vital for patient safety and effective treatment
Injection-site reactions Bruising, redness, or mild pain at the injection site Tips: rotate the injection site every week (abdomen, thigh, upper arm), do not reuse needles , and avoid areas that are tender, scarred, or with stretch marks
Why GLP-1 Medications Do Not Resolve Root Metabolic Dysfunction While GLP-1 agonists can improve glycemic control and suppress appetite, they do not address the underlying drivers of metabolic dysfunction
By activating these receptors, tirzepatide helps the body release more insulin when blood sugar levels are high, reduces the amount of sugar released by the liver, and makes you feel fuller after eating
and many other countries are tested for PKU right after birth," Maples says